期刊文献+

吡啶斯的明试验对评价垂体hGH储备功能的价值 被引量:4

THE VALUE OF PYRIDOSTIGMINE IN EVALUATION OF GH RESERVE IN CHILDREN AND ADOLESCENTS
原文传递
导出
摘要 作者试用胆碱酯酶抑制剂吡啶斯的明兴奋hGH释放,并与胰岛素兴奋hGH试验作比较,观察了13例正常青少年和8例垂体性侏儒症患者对两种兴奋试验的反应。结果显示口服吡啶斯的明2mg/kg体重能迅速有效地兴奋垂体hGH释放,其作用较胰岛素兴奋试验更为强大,是一项值得推荐的判定青少年垂体hGH储备功能的试验。 In the present study, we observed the effects of cholinergic enhancement by pyridostigmine (PD), a cholinesterases inhibitor, on GH release in both normal (n = 13) and GH deficient children and adolescents (n = 8). Responses of GH to insulin hypoglycemia were also observed. In the normal subjects, PD-induced serum GH peak levels were significantly higher than that induced by insulin (P<0.0l). By contrast, the GH level in the patients with pituitary dwarfism showed no increase by both tests. The study indicates that PD test may be considered as a sensitive dynamic test in evaluating pituitary function of GH secretion in children and adolescents.
出处 《中华内分泌代谢杂志》 CAS CSCD 北大核心 1990年第4期201-202,共2页 Chinese Journal of Endocrinology and Metabolism
关键词 垂体生长激素 吡啶斯的明 侏儒症 Growth hormone Pyridostigmine Insulin Dwarfism
  • 相关文献

参考文献2

  • 1张建,中华内分泌代谢杂志,1987年,3卷,129页
  • 2诸福棠,实用儿科学.上,1985年

同被引文献16

  • 1吴天星,金小军,章开训.苯二氮类化合物对小狄高鸡消化功能和生产性能的影响[J].浙江农业大学学报,1994,20(4):369-373. 被引量:1
  • 2李堂,杜嗣廉,林荣军.吡啶斯的明对生长激素缺乏症儿生长激素分泌的激发作用[J].实用儿科临床杂志,1996,11(2):83-84. 被引量:4
  • 3李永昶.小儿内分泌学[M].北京:人民卫生出版社,1981.27.
  • 4池芝盛,内分泌学基础与临床,1992年,124页
  • 5王小东,中华内分泌代谢杂志,1990年,6卷,4期,202页
  • 6李永昶,小儿内分泌学,1981年,27页
  • 7Rosenfeld NG, Albertsson-Wikland K, Cassorla F, et al. Diagnostic controversy: the diagnosis of childhood growth hormone deficiency revisited. J Clin Endocrinol Metab, 1995,80:1532-1540.
  • 8Tanner JM, Davies PSW. Clinical longitudinal standards for height and height velocity for North American children. J Pediatr, 1985,107:317-329.
  • 9Ghigo E, Bellone J, Aimaretti G, et al. Reliability of provocative tests to assess growth hormone secretory status. Study in 472 normally growing children. J Clin Endocrinol Metab, 1996,81:3323-3327.
  • 10Friend K, Iranmanesh A, Login IS, et al. Pyridostigmine treatment selectively amplifies the mass of GH secreted per burst without altering GH burst frequency, half-life, basal GH secretion or the orderliness of GH release. Eur Endocrinol J, 1997,137:377-3

引证文献4

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部